Evonik

Evonik’s Health Care business serves as an innovation hub to leading global pharmaceutical, medical device and nutraceutical companies. Our broad, versatile portfolio of functional excipients, technologies and CDMO services for oral and parenteral dosage forms makes us a global leader for advanced drug delivery. We also serve as a global CDMO for small molecule APIs, HPAPIs and intermediates, and supply high-quality, innovative cell culture solutions. Evonik operates a trusted global network of manufacturing sites, laboratories and development centers around the world. We have a track record of providing enabling solutions to more than 1,000 pharmaceutical, med-tech and nutraceutical customers worldwide, including 90% of the world’s top life-science companies.

SEE EVONIK EXCIPIENTS IN THE SHOP

Oral Drug Delivery Solutions

Evonik is a leader in comprehensive oral drug delivery solutions, dedicated to maximizing the potential of active pharmaceutical ingredients (APIs). With over 70 years of experience, we partner with pharmaceutical and biotech companies to enhance drug performance, streamline complexity, and accelerate time to market while ensuring robust supply security.

Our extensive EUDRAGIT® functional excipients enable versatile release profiles—immediate, delayed, controlled, and more—catering to diverse oral solid dosage requirements. These polymers provide high compatibility with processing technologies, available in various forms for efficient handling.

We also offer proprietary oral drug delivery technologies designed for seamless integration with EUDRAGIT® polymers, optimizing drug targeting and performance. This includes pH- and time-dependent systems for targeted delivery to the ileocolonic region, enhancing enteric protection and bioavailability.

Leveraging the functionality of EUDRAGIT® polymers, Evonik has developed the range of ready-to-fill functional capsules EUDRACAP®. Each standard or custom EUDRACAP® configuration features a smooth, homogeneous coating of EUDRAGIT® for precise pH targeting.

Our formulation development services help create complex oral dosage forms such as matrix tablets and multiparticulates, utilizing our experts and advanced laboratory network. Our GMP-compliant clinical manufacturing facility in Germany supports phase I and II clinical trials.

Learn more about the Evonik healthcare´s portfolio for oral drug delivery

Parenteral Drug Delivery Solutions

Evonik is one of the leading CDMOs for complex parenteral drug products, such as LNP formulations for mRNA delivery, gene therapies and nanomedicines. Services include the formulation, process development, GMP manufacturing, and aseptic filling for drugs that use lipid-based or polymeric delivery technologies. We also offer custom manufactured GMP lipids and PhytoChol® vegetal-derived cholesterol for injectable lipid nanoparticle (LNP) formulations.

Our other excipients for parenteral drugs include the market leading RESOMER® and LACTEL® portfolio of bioresorbable polymers for extended release and CMO services for proprietary excipients. LIPEX® Flow extruders are offered for liposome manufacturing at all scales.

Regardless of the stage of drug development, our expertise, technologies, high-quality sites, and strong regulatory track record can help reduce project risk and improve supply security.

Learn more about Evonik Healthcare´s portfolio for parenteral drug delivery:

PARENTERAL DRUG DELIVERY